The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan-Reference-Cited by-同舟云学术

The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan

Published:2022-09 Issue: Volume:153 Page:113391
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Grześk Grzegorz,Wołowiec Łukasz,Rogowicz Daniel,Gilewski Wojciech,Kowalkowska Mirosława,Banach Joanna,Hertmanowski Wojciech,Dobosiewicz Małgorzata

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference73 articles.

1. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden;Thorvaldsen;Int. J. Cardiol.,2014

2. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial;Follath;Lancet,2002

3. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure;Bahl;J. Am. Coll. Cardiol. HF Indian Heart J.,2013

4. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure;Slawsky;Circulation,2000

5. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery;Mehta;N. Engl. J. Med.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1;Heliyon;2024-04

2. Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis;ESC Heart Failure;2024-02-28

3. Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study;International Journal of Molecular Sciences;2024-02-02

4. Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up;Annals of Medicine;2024-01-23

5. Current Targets and Future Directions of Positive Inotropes for Heart Failure;Current Medicinal Chemistry;2023-10-31